Cargando…
Circulating tumor DNA (ctDNA) detection is associated with shorter progression-free survival in advanced melanoma patients
BRAF, NRAS and TERT mutations occur in more than 2/3 of melanomas. Its detection in patient’s blood, as circulating tumor DNA (ctDNA), represents a possibility for identification and monitoring of metastatic disease. We proposed to standardize a liquid biopsy platform to identify hotspot mutations i...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7596487/ https://www.ncbi.nlm.nih.gov/pubmed/33122747 http://dx.doi.org/10.1038/s41598-020-75792-1 |